Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COMETRIQ for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where COMETRIQ was used for Lung neoplasm malignant.

Most Reported Side Effects for COMETRIQ

Side Effect Reports % Deaths Hosp.
Off label use 75 49.7% 19 11
Fatigue 48 31.8% 8 9
Diarrhoea 39 25.8% 10 7
Stomatitis 29 19.2% 2 6
Nausea 23 15.2% 2 6
Death 20 13.3% 20 7
Decreased appetite 18 11.9% 6 4
Dry mouth 16 10.6% 0 1
Malignant neoplasm progression 16 10.6% 13 3
Pain in extremity 16 10.6% 1 1
Dysgeusia 15 9.9% 0 2
Dysphonia 15 9.9% 3 2
Asthenia 14 9.3% 3 7
Dyspnoea 13 8.6% 4 3
Hair colour changes 10 6.6% 0 1

Other Indications for COMETRIQ

Thyroid cancer (64) Prostate cancer (28) Renal cancer (18) Medullary thyroid cancer (10)

Other Drugs Used for Lung neoplasm malignant

ERLOTINIB (9,207) OSIMERTINIB (4,754) NIVOLUMAB (4,197) PEMBROLIZUMAB (3,575) CARBOPLATIN (3,487) ALECTINIB (2,932) PEMETREXED (2,422) CRIZOTINIB (1,949) BEVACIZUMAB (1,810) PACLITAXEL (1,747)

Related Pages

COMETRIQ Full Profile All Lung neoplasm malignant Drugs COMETRIQ Demographics COMETRIQ Timeline